← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2016Last known activity
Dec 31, 2020
Acquired by Redx Pharma Plc
Timeline
2010s
- Jun 1, 2013
Jounce Therapeutics, Inc.— Founded
Drugs by trial phase (6 distinct, 6 trials)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT04669899Study directorPhase 1Dec 31, 2020
- NCT04669899Lead sponsorPhase 1Dec 31, 2020
- NCT04549025Lead sponsorPhase 2Oct 19, 2020
- NCT04549025Study directorPhase 2Oct 19, 2020
- NCT04319224Study directorPhase 1/Phase 2Mar 10, 2020
- NCT04319224Lead sponsorPhase 1/Phase 2Mar 10, 2020
- NCT03989362Lead sponsorPhase 2Jun 6, 2019
- NCT03989362Study directorPhase 2Jun 6, 2019
- NCT03790488Study directorPhase 1Dec 6, 2018
- NCT03790488Lead sponsorPhase 1Dec 6, 2018
- NCT02904226Lead sponsorPhase 1/Phase 2Aug 1, 2016
- NCT02904226Study directorPhase 1/Phase 2Aug 1, 2016
Details
- Founded
- Cambridge, MA, US Jun 1, 2013
- Last known activity
- Dec 31, 2020